InSightec Ltd., an Israeli developer of magnetic resonance-guided ultrasound technology, says that its ExAblate system has been used for the first time for the treatment of prostate cancer patients. Seven patients with localized low-risk prostate cancer were treated so far at the N.N. Petrov Research Institute of Oncology in Saint Petersburg, Russia, and at the . . . → Read More: Prostate Cancer Patients Treated with Robotic Ultrasound
|
|||||
       |
Results from a proof-of-concept clinical trial of the drug MP4OX in severely injured trauma patients with hemorrhagic shock showed that MP4OX, when given in addition to standard of care, was effective at decreasing lactate levels in treated patients. MP4OX is an oxygen therapeutic agent that is designed to provide rapid oxygen delivery to tissues with . . . → Read More: Trial Shows Drug Reduces Lactic Acid in Trauma Patients Rice University scientists in Houston, Texas have created the first two-terminal memory silicon chips that can be manufactured with nanoelectronic techniques and promise to extend the limits of miniaturization subject to Moore’s Law, which states the number of devices on a circuit doubles every 18 to 24 months. Professor James Tour initially showed how electrical . . . → Read More: Nanoscale Silicon Oxide Circuits Break Memory Barrier The U.S. Biomedical Advanced Research and Development Authority (BARDA) awarded a contract to Achaogen Inc. of San Francisco, California to develop an antibiotic against two types of bioterrorism as well as common infections that are becoming resistant to antibiotics. The contract pays Achaogen $27 million in the first two years, but can be extended annually . . . → Read More: Contract Awarded for Bioterror Antibiotic The U.S. Food and Drug Administration (FDA) wants to learn more about the safety and effectiveness of medical devices made with or from nanotechnology, and has scheduled a public workshop to find out. The session is set for Wednesday, 23 September 2010 in Gaithersburg, Maryland. According to the notice of the meeting … FDA would . . . → Read More: FDA Holding Workshop on Nanotech and Medical Devices Bend Research Inc., a developer of drug formulation technology in Bend, Oregon, says it received a U.S. patent covering a process for making spray-dried solid amorphous dispersions of drugs using pressure nozzles. The patent — No. 7,780,988 assigned by the U.S. Patent and Trademark Office — covers a spray-drying process for producing solid amorphous dispersions . . . → Read More: Patent Awarded for Drug Spray/Dispersion Technology Two European universities, one research institute, and a computer security company developed a technique to exploit imperfections in quantum cryptography systems, then created a countermeasure for it. Quantum cryptography allows the distribution of a cryptographic key across an optical network, then applies the laws of quantum physics to guarantee its secrecy. The technique uses the . . . → Read More: Collaboration Finds Cryptography Flaw, Creates Countermeasure The Semiconductor Industry Association (SIA) reports today that global sales of semiconductors grew in value to $25.2 billion in July, an increase of 1.2 percent from June when sales were $24.9 billion. This level also represents an increase of 37 percent over July 2009’s sales of $18.4 billion. SIA says that year to date chip . . . → Read More: Worldwide Semiconductor Sales Rise in July SonoSite Inc. of Bothell, Washington, a maker of ultrasound medical devices, says it received U.S. Food and Drug Administration clearance for its LumenVu Catheter Guidance System, designed to direct the placement of peripherally inserted central catheters (PICC). The company says LumenVu combines near-infrared technology with a fiber optic stylet, which replaces a traditional guide wire, . . . → Read More: FDA Clears Catheter Guidance System The U.S. Food and Drug Administration (FDA) approved the drug Tekamlo to treat high blood pressure, made by pharmaceutical manufacturer Novartis of East Hanover, New Jersey. Tekamlo tablets combine the renin inhibitor aliskiren with the calcium channel blocker amlodipine. FDA approved Tekamlo as an initial therapy for patients who are likely to need multiple drugs . . . → Read More: FDA Approves New Blood Pressure Drug |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
Comments are closed 
RSS - Posts
You must be logged in to post a comment.